Analysts expect over 2023 shrinking sales Galapagos

Tomorrow the Belgian company Galapagos will publish its past quarter results. Over the current book year the company from could achieve a revenue around 521.23 million euros (consensus estimates). This is slightly lower than 2022's revenue of 552.13 million euros.

Historical revenues and results Galapagos plus estimates 2023

Carrefour Warsaw store © Galapagos

The analysts expect for 2023 a net loss of 173 million euros. The majority of the analysts expects for this year a loss per share of 2.69 euros. The price/earnings-ratio therefore equals -11.61.

For this year analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies is an attractive 3.55 percent.

Most recent target prices around 46 euros

The most recent recommendations for the biotech company are from Citigroup , JP Morgan and Jefferies & Co..

Based on the current number of outstanding shares Galapagos 's market capitalization 2.05 billion euros.

At 17.35 the stock trades 0.64 percent higher at 31.23 euros.

Historical stock prices Galapagos past 17 years

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.